CivaTech Oncology

CivaTech Oncology, based in Research Triangle Park, Durham, NC, the United States, is a medical device company. CivaTech Oncology develops brachytherapy devices, including a flexible, bioabsorbable, polymer-encapsulated planar radiation source for treating solid tumours with minimal patient trauma. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials in pancreatic ductal adenocarcinoma and non-small-cell lung cancer. The largest, NCT02843945 (Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source), plans to enrol 80 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.